Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
177Lu-PSMA-617 for metastatic prostate cancer in India.
Ghose A, Banerjee S, Choudhury PS, Maniam A, Gupta M, Banna GL, Vasdev N, Ghose A, Noronha V, Mitra S. Ghose A, et al. Among authors: banna gl. Lancet Reg Health Southeast Asia. 2024 Sep 12;30:100484. doi: 10.1016/j.lansea.2024.100484. eCollection 2024 Nov. Lancet Reg Health Southeast Asia. 2024. PMID: 39309758 Free PMC article. No abstract available.
Antibody Drug Conjugates in Urological Cancers: A Review of the Current Landscape.
Ghose A, Lapitan P, Apte V, Ghosh A, Kandala A, Basu S, Parkes J, Shinde SD, Boussios S, Sharma A, Das P, Vasdev N, Rebuzzi SE, Ürün Y, Kanesvaran R, Maniam A, Banna GL. Ghose A, et al. Among authors: banna gl. Curr Oncol Rep. 2024 Jun;26(6):633-646. doi: 10.1007/s11912-024-01524-7. Epub 2024 Apr 23. Curr Oncol Rep. 2024. PMID: 38652426 Review.
Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study.
Maiorano BA, Catalano M, Mercinelli C, Roviello G, Maruzzo M, De Giorgi U, Chiellino S, Sbrana A, Galli L, Zucali PA, Masini C, Naglieri E, Procopio G, Merler S, Fratino L, Baldessari C, Ricotta R, Mollica V, Sorarù M, Tudini M, Prati V, Malgeri A, Atzori F, Napoli MD, Caffo O, Spada M, Morelli F, Prati G, Nolè F, Vignani F, Cavo A, Lipari H, Puglisi S, Signori A, Necchi A, Banna GL, Fornarini G, Buti S, Rebuzzi SE. Maiorano BA, et al. Among authors: banna gl. Clin Genitourin Cancer. 2024 Nov 10;23(1):102267. doi: 10.1016/j.clgc.2024.102267. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39603144
Prognostic factors and treatment choice for stage IV, low-volume metastasis hormone-sensitive prostate cancer: cross-sectional study of real-world data.
Elewaily MI, Campione M, Hassan MA, Anpalakhan S, Atsumi N, Smalley B, Ashraf A, Gale J, Maniam A, Banna GL. Elewaily MI, et al. Among authors: banna gl. Ther Adv Urol. 2024 Nov 12;16:17562872241297579. doi: 10.1177/17562872241297579. eCollection 2024 Jan-Dec. Ther Adv Urol. 2024. PMID: 39539668 Free PMC article.
Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab.
Damassi A, Cremante M, Signori A, Rebuzzi SE, Malgeri A, Napoli MD, Caffo O, Vignani F, Cavo A, Roviello G, Prati V, Tudini M, Atzori F, Messina M, Morelli F, Prati G, Nolè F, Catalano F, Murianni V, Rescigno P, Banna GL, Fornarini G, Buti S. Damassi A, et al. Among authors: banna gl. Immunotherapy. 2024;16(18-19):1095-1103. doi: 10.1080/1750743X.2024.2385881. Epub 2024 Aug 19. Immunotherapy. 2024. PMID: 39155821
185 results